logo
Trump Is Trying to Hide the Cost of Renovating His New Air Force One

Trump Is Trying to Hide the Cost of Renovating His New Air Force One

Yahooa day ago
How much will it cost to renovate the Boeing 747-8 gifted by Qatar into the next Air Force One? That's classified information. But a recent $934 million transfer of funds to a Pentagon budget may hold a clue.
The New York Times reported that this 'transfer' to an unnamed classified project described in a Pentagon document sent to Capitol Hill likely includes the cost of renovating the gifted plane into a lavish gold-accented flying palace for President Trump. The funds were moved to a budget dedicated to updating America's ground-based nuclear missiles, and Air Force officials told the paper that at least some of the funds for the renovations will come from the nuclear modernization project.
Making the project even more absurd, because the renovations will take one or two years to complete, Trump will only fly in the plane as president for a short time until he leaves office and the plane is ostensibly transferred to his presidential library in 2029 — at least that is what Trump has said will happen. (Unless, that is, Trump finds a way to extend his time in office beyond this four year term, as he has often hinted at, though that would be extremely unconstitutional.)
Among the improvements to the plane are upgrades to its communications systems and engines as well as the addition of antimissile systems. Plus, U.S. intelligence will need to identify and remove any covert listening devices that Qatar may have embedded in the plane's walls. Finally, the plane will be treated to similar internal decor to the Oval Office, which Trump has outfitted with tacky gold accents.
Trump pursued the gift from Qatar, he said, because Boeing is years behind schedule to deliver two new planes to serve as Air Force Ones, a project that has already cost $4 billion.
Air Force Secretary Troy E. Meink testified to Congress in June about the cost to renovate the Qatar plane.
'I think there has been a number thrown around on the order of $1 billion,' he said. 'But a lot of those costs associated with that are costs that we'd have experienced anyway, we will just experience them early,' ahead of Boeing's scheduled delivery of its new Air Force Ones. 'So it wouldn't be anywhere near that.'
He added, 'We believe the actual retrofit of that aircraft is probably less than $400 million.'
But engineers and Air Force experts familiar with this kind of work shed doubt on that price tag, and members of Congress have voiced worries that Trump will want to use the plane quickly, and he will push the Air Force to complete the work before installing proper safety mechanisms.
While the Pentagon will reveal the price to modernize America's ground-base nuclear missiles, it declined to share with the Times just how much the plane upgrades will cost.
'The more we learn about this deal, the more disturbing it becomes,' Democratic Sen. Jeanne Shaheen told the paper. 'The security implications of accepting a private plane from a foreign nation as Air Force One and the resulting ethical concerns a gift of that sizes creates were already significant.'
She also expressed concern that 'this administration is diverting funds from the nuclear modernization budget to finance costly renovations to this plane,' which means the U.S. is 'weakening our credibility to fund a vanity project for President Trump.'
More from Rolling Stone
Israel Seizes Aid Flotilla Bringing Baby Formula, Medicine to Gaza
Oklahoma's Trump-Loving, Bible-Thumping Superintendent Faces Porn Probe
The Democratic Party's Brand Is Cooked
Best of Rolling Stone
The Useful Idiots New Guide to the Most Stoned Moments of the 2020 Presidential Campaign
Anatomy of a Fake News Scandal
The Radical Crusade of Mike Pence
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings
Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings

Yahoo

time18 minutes ago

  • Yahoo

Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings

Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Wednesday afternoon. Here's what investors should know. Hologic met analysts' revenue expectations last quarter, reporting revenues of $1.01 billion, down 1.2% year on year. It was a slower quarter for the company, with a slight miss of analysts' full-year EPS guidance estimates and full-year revenue guidance meeting analysts' expectations. Is Hologic a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Hologic's revenue to be flat year on year at $1.01 billion, slowing from the 2.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.05 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Hologic has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 0.9% on average. Looking at Hologic's peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Scientific delivered year-on-year revenue growth of 22.8%, beating analysts' expectations by 3.4%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Boston Scientific traded up 2.9% following the results while Intuitive Surgical was down 1.9%. Read our full analysis of Boston Scientific's results here and Intuitive Surgical's results here. Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. Hologic is up 2.8% during the same time and is heading into earnings with an average analyst price target of $69.93 (compared to the current share price of $66.99). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio

CONMED (CNMD) Q2 Earnings: What To Expect
CONMED (CNMD) Q2 Earnings: What To Expect

Yahoo

time18 minutes ago

  • Yahoo

CONMED (CNMD) Q2 Earnings: What To Expect

Medical tech company CONMED (NYSE:CNMD) will be announcing earnings results this Wednesday after market close. Here's what to look for. CONMED beat analysts' revenue expectations by 2.6% last quarter, reporting revenues of $321.3 million, up 2.9% year on year. It was a very strong quarter for the company, with a solid beat of analysts' full-year EPS guidance estimates and an impressive beat of analysts' EPS estimates. Is CONMED a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting CONMED's revenue to grow 1.9% year on year to $338.3 million, slowing from the 4.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.12 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. CONMED has missed Wall Street's revenue estimates three times over the last two years. Looking at CONMED's peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Scientific delivered year-on-year revenue growth of 22.8%, beating analysts' expectations by 3.4%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Boston Scientific traded up 2.9% following the results while Intuitive Surgical was down 1.9%. Read our full analysis of Boston Scientific's results here and Intuitive Surgical's results here. Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. CONMED is down 4% during the same time and is heading into earnings with an average analyst price target of $66.60 (compared to the current share price of $50.02). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Kraft Heinz (KHC) Reports Q2: Everything You Need To Know Ahead Of Earnings
Kraft Heinz (KHC) Reports Q2: Everything You Need To Know Ahead Of Earnings

Yahoo

time18 minutes ago

  • Yahoo

Kraft Heinz (KHC) Reports Q2: Everything You Need To Know Ahead Of Earnings

Packaged foods company Kraft Heinz (NASDAQ:KHC) will be reporting results this Wednesday before market open. Here's what investors should know. Kraft Heinz met analysts' revenue expectations last quarter, reporting revenues of $6.00 billion, down 6.4% year on year. It was a mixed quarter for the company, with a narrow beat of analysts' EBITDA estimates but full-year EPS guidance missing analysts' expectations. Is Kraft Heinz a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Kraft Heinz's revenue to decline 3.1% year on year to $6.27 billion, in line with the 3.6% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.64 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 4 downward revisions over the last 30 days (we track 10 analysts). Looking at Kraft Heinz's peers in the shelf-stable food segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Lamb Weston delivered year-on-year revenue growth of 4%, beating analysts' expectations by 5.7%, and McCormick reported flat revenue, in line with consensus estimates. Lamb Weston traded up 19.3% following the results while McCormick was also up 3.6%. Read our full analysis of Lamb Weston's results here and McCormick's results here. There has been positive sentiment among investors in the shelf-stable food segment, with share prices up 3.8% on average over the last month. Kraft Heinz is up 9.3% during the same time and is heading into earnings with an average analyst price target of $30.18 (compared to the current share price of $28.22). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store